Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.535 USD | +0.09% | +75.71% | +28.12% |
06-25 | Maxim Downgrades Alimera Sciences to Hold From Buy | MT |
06-25 | Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.12% | 290M | |
+2.99% | 94.76B | |
-3.68% | 37.58B | |
-9.44% | 33.3B | |
+75.48% | 27.92B | |
-13.09% | 15.85B | |
-4.08% | 13.79B | |
-12.21% | 11.51B | |
+188.83% | 10.9B | |
-53.94% | 9.27B |
- Stock Market
- Equities
- ALIM Stock
- News Alimera Sciences, Inc.
- Sector Update: Health Care Stocks Advance Premarket Monday